
The Anticoagulation Forum publishes 3-4 newsletters annually. Content from our newsletters is put on our Web site as a way to share information for the mutual growth and development of professionals in the anticoagulation field.
This issue includes an article about The Hemophilia & Thrombosis Research Society, updates from the NCBAP highlighting changes to the CACP process, and an announcement from the NATT Board of Directors about its new name change to the National Blood Clot Alliance. Also featured on the front page is the discussion “The Importance of the Control Group to Assess the Benefits of Home Monitoring” by Jack Ansell, M.D.
Say goodbye to conference calls and hello to latest in computer technology: the webinar. No longer do people have to move from their desks to attend a meeting. Join the AC Forum Lunch and Learn Journal Club by webinar. This issue also includes news about the AC Forum Conference, Case Vignettes, NATT Update and an NCBAP Update.
In February of 2008 a group of 24 of the nation’s leading experts in oral anticoagulation management and reimbursement, gathered to develop a guideline for healthcare professionals to provide a practical, seamless process for the implementation of patient self-testing (PST). The group was comprised of cardiologists, internist, family physicians, hematologist, RNs, Advanced Practice Nurses, PharmDs, health plan administrators and reimbursement consultants.
This special edition of the Anticoagulation Forum newsletter contains the full article titled Delivery of Optimized Anticoagulant Therapy: A Consensus Statement from the Anticoagulation Forum published in the Annals of Pharmacotherapy in July 2008. This article updates the paper published in 1997 by Jack Ansell and the Anticoagulation Guidelines Task Force titled Consensus Guidelines for Coordinated Outpatient Oral Anticoagulation Therapy Management.
This issue of the newsletter explains the billing codes and other details of the Medicare expanded coverage for INR patient home monitoring. The newsletter also includes a new column on successful anticoagulation clinics and a new issue of Anticoagulation Updates from the Literature.
This edition of the newsletter contains an informative article entitled Emerging Anticoagulants in the Management of Venous Thromboembolism by Dr. Alex Spyropoulos. Other articles include a new edition of Anticoagulation Updates from the Literature, updates from NATT and NCBAP, and the AC Forum’s new address and contact information.
This Anticoagulation Forum newsletter includes a copy of the letter sent to the Centers for Medicare and Medicaid Services in support of expanded coverage for patient self-testing, announces NATT's large grant from the CDC, and includes a chart outlining the many organizations working in the field of thrombosis.
This issue of the newsletter includes a letter from the AC Forum Board of Directors to Dr. Lawrence Lesko, Director, Office of Clinical Pharmacology at the FDA. The letter outlines the AC Forum's concerns about the FDA's plan to add information about genotype testing to the warfarin package insert. The newsletter also includes Dr. Lesko's response letter.
The Anticoagulation Forum’s 9th National Conference on May 3-5 in Chicago is just a few months away. Be sure to register soon. Dr. Jack Ansell steps down as president and Dr. David Garcia introduces his vision for the AC Forum’s future. Also included is a commentary by Mark Crowther, MD on “Fixed-Dose Unfractionated Heparin for the Treatment of Venous Thromboembolism”.
This issue features a study investigating the interaction between cranberry juice and warfarin, introduces new members of the AC Forum Board of Directors, and offers free copies of the 8th National Conference proceeding published by the Journal of Thrombosis and Thrombolysis.
This issue announces that Chicago will be the site for the next Anticoagulation Forum conference - May 3-5, 2007. Also included is an article on "Understanding the Variability of Warfarin Dosing" and updates from the National Alliance on Thrombosis and Thrombophilia (NATT) and from the National Certification Board of Anticoagulation Providers (NCBAP) including a list of the newest CACPs.
The 8th National Conference is just 2 months away. Please view the newsletter for more details. Also in this issue, Dr. Jack Ansell discusses "What Happened to Ximelagatran?" Read updates from the National Alliance for Thrombosis and Thrombophilia, the National Certification Board of Anticoagulation Providers (including information on the recertification process) and information from the NIH conference on Dietary Supplements, Coagulation, and Antithrombotic Therapies.
This edition contains new information on long-term, secondary treatment of deep venous thrombosis, a CACP credentialing update as well as details on a National Consumers League campaign to improve senior outpatient medication safety.
.
